| pubmed-article:11693900 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:11693900 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:11693900 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11693900 | pubmed:dateCreated | 2001-11-5 | lld:pubmed |
| pubmed-article:11693900 | pubmed:abstractText | The purpose of this study was to determine the clinical, pathological, and treatment factors that are predictive of local-regional recurrence and overall survival for patients with breast cancer that is refractory to neoadjuvant chemotherapy. | lld:pubmed |
| pubmed-article:11693900 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11693900 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11693900 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11693900 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11693900 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11693900 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11693900 | pubmed:issn | 1528-9117 | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:HillB SBS | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:HortobagyiG... | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:BuzdarA UAU | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:TuckerS LSL | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:BuchholzT ATA | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:SingletaryS... | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:ValeroVV | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:McNeeseM DMD | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:PusztaiLL | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:FryeD KDK | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:KuererH MHM | lld:pubmed |
| pubmed-article:11693900 | pubmed:author | pubmed-author:UenoN TNT | lld:pubmed |
| pubmed-article:11693900 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11693900 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:11693900 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11693900 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11693900 | pubmed:pagination | 413-20 | lld:pubmed |
| pubmed-article:11693900 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:meshHeading | pubmed-meshheading:11693900... | lld:pubmed |
| pubmed-article:11693900 | pubmed:articleTitle | Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. | lld:pubmed |
| pubmed-article:11693900 | pubmed:affiliation | Department of Radiation Oncology,The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. | lld:pubmed |
| pubmed-article:11693900 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11693900 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11693900 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11693900 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11693900 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11693900 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11693900 | lld:pubmed |
